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ABSTRACT 
 
Background: Myocardium contracts in the beginning of ejection causing outflow 
acceleration, resulting in asymmetric outflow velocity profiles peaking around 1/3 of ejection 
and declining when force development declines.  
Aims: To demonstrate that decreased contractility in coronary artery disease (CAD) changes 
outflow timing and profile symmetry. 
Methods and results: 79 patients undergoing routine full dose dobutamine stress-echo 
(DSE) were divided into 2 groups based on resting wall-motion and DSE-response: DSE 
negative (DSEneg) (35/79) and positive (DSEpos) (44/79) which were compared to 32 healthy 
volunteers. Aortic CW-Doppler traces at rest were analyzed semi-automatically; time-to-peak 
(Tmod), ejection-time (ETmod), rise- (trise) and fall-time (tfall) were quantified. Asymmetry 
(asymm) was calculated as the normalized difference of left and right half of the spectrum.  
Normal curves were triangular, early-peaking, while patients showed more rounded shapes 
and later peaks. Trise was longest in DSEpos. Tfall was shortest in DSEpos, followed by controls 
and DSEneg. Asymm was lowest in DSEpos, followed by controls and DSEneg. 
Abnormally symmetric profiles (asymm<0.25) were found in none of the controls, 2.9% 
DSEneg and 27.3% DSEpos. A good correlation was found between assym and ejection 
fraction (EF) and Tmod/ETmod and EF. 
Notably, an LV dynamic gradient was induced in 71.4% DSEneg and in 18.2% DSEpos, 
associated with LV hypertrophy and supernormal (very asymmetric) traces. 
Conclusions: Decreased myocardial function results in a more symmetrical outflow, while 
very asymmetrical traces suggest increased contractility, potentially inducing intra-cavity 
gradients during DSE. Therefore, including outflow symmetry as a clinical measurement 
provides additional information on patients with CAD. 
 
KEY WORDS: Left ventricular outflow trace, Doppler echocardiography, dobutamine stress 
echocardiography, left ventricular function, haemodynamics. 
INTRODUCTION 
 
Blood pool Doppler echocardiography provides a method to measure blood velocities within 
the ventricles and blood vessels [1]. By measuring velocities through the cardiac valves, the 
amount of flow (cardiac output, filling) and the driving pressure gradient, causing the flow, 
can be quantified [1-9], which can be clinically used to assess hemodynamic parameters and 
ventricular function [1-6].  
The profile of the aortic flow velocity curves can be described by the rate of increase 
(acceleration) in velocity, the peak and the time of peak velocity, the mean velocity during 
systole and the ejection duration [1]. Normal outflow shows an asymmetric, triangular shaped 
profile with a fast rise in velocities, peaking around 1/3 of the ejection duration [1]. Animal 
studies have shown that the flow acceleration is a sensitive indicator of the inotropic state 
[10], which was confirmed by clinical research [5,11]. In LV failure, both a lower and a slower 
increase in velocities (a more rounded Doppler profile with a later peak velocity) was 
observed [1]. Similar changes can be present in normal function but decreased filling (i.e. 
severe mitral stenosis, atrial septal defect, pulmonary hypertension) [1]. Changes in aortic 
velocity curves have been reported in other conditions such as hypertrophic cardiomyopathy 
[12], mitral regurgitation [13] and shock [14]. Furthermore, flow remodelling is regularly seen 
in aortic stenosis where, besides an increasing gradient, the profile changes from a triangular 
shape with an early peak, to a much more rounded form with a later peak in higher grade 
stenoses [1, 8].  
Additionally, it is known that active force development in the myocytes peaks around 1/3 of 
the ejection, after which it decreases rapidly [15]. This implies that the early flow acceleration 
is caused by the active contraction, while flow decelerates when force development declines. 
This explains why flow acceleration increases with increased contractility. Additionally, 
research on isolated myocytes suggested that chronic ischaemia decreases, but prolongs 
contraction [16].  
 
From this, we hypothesize that in the presence of coronary artery disease, in a subset of 
patients, the overall decrease in contractility caused by regional ischaemia and a slower 
contraction of chronic ischaemic myocytes, might be reflected in the aortic outflow profile, 
particularly in the timing and shape of the LV outflow curve and that these changes are 
related to the severity of contractile dysfunction. In order to study this relation and its 
usefulness in providing diagnostic clinical information, we propose a novel method for 
Doppler signal analysis where various properties of the envelope of the aortic outflow are 
quantified.  
 
 
MATERIALS AND METHODS 
 
Patients  
From a retrospective series of 109 patients which were referred for a routine dobutamine 
stress echo (DSE) at St. George’s hospital (London, UK), 79 (37 male, 42 female, mean age 
62.7±9.4 years) had sufficient visualization of all myocardial walls and interpretable 
continuous Doppler (CW) LV outflow traces and did not have increased outflow velocities at 
rest (baseline) due to either aortic stenosis or the presence of an intra-cavity gradient. 
Furthermore, none of these patients had significant valve disease or left bundle branch block. 
In patients prescribed with beta blocker therapy, it was discontinued three days prior to the 
study.  
Based on the resting wall motion and the response to the dobutamine challenge, the patients 
were divided in 2 subgroups.  
The DSE negative group (DSEneg) consisted of 35 patients without resting wall motion 
abnormalities and a (quantitative) DSE study without signs of inducible ischaemia (9 male, 
26 female, 60.3±8.4 years). 
The DSE positive group (DSEpos) consisted of 44 patients with a DSE study showing signs 
of ischaemic heart disease, either at baseline or during any of the stress levels (28 male, 16 
female, 64.7±9.7 years).  
Additionally, 32 healthy volunteers with no signs or symptoms of cardiovascular disease or 
arterial hypertension were studied at baseline (not undergoing an DSE study) and served as 
a control group (15 male, 17 female, 59.1±11.5 years). The investigation conforms with the 
principles outlined in the Declaration of Helsinki.  
 
Echocardiographic imaging 
Standard cardiac ultrasound data (including Doppler myocardial imaging (DMI)) at baseline 
(healthy volunteers and patients) and during the DSE (patients) were acquired with a Vivid 
Seven ultrasound scanner equipped with a 2.5-MHz transducer (GE, Horten, Norway). Data 
were obtained from the parasternal and apical views. For the 2D studies, parasternal long 
and short axis as well as apical two-, three-, four- and five-chamber views were used. Aortic 
outflow CW Doppler traces were acquired from the apical five-chamber view. The 
echocardiographic data were obtained for three complete cardiac cycles during a single end-
expiratory breath hold. 
For the DSE study, dobutamine was infused at rates of 5, 10, 15, 20, 30 and 40 mcg/kg/min 
and increased with 3 min steps until reaching 85% of age-predicted heart rate (HR) (target 
HR). The study was interrupted earlier in the presence of induced ischaemia, occurrence of 
severe symptoms, raised blood pressure (BP) or upon reaching target HR. 
Echocardiographic data, together with BP and a 12-lead ECG, were acquired at low (5 
mcg/kg/min), intermediate (20 mcg/kg/min), peak dose (40 mcg/kg/min) and recovery. DMI 
data were simultaneously acquired for post-processing. At each stage, CW Doppler traces of 
aortic flow were additionally acquired. 
The presence of echocardiographic signs of ongoing ischaemic heart disease was evaluated 
by two experienced cardiologists, both by assessment of regional wall motion abnormalities 
[17], as well as by analysis of the underlying DMI data [18].  
Offline analysis was performed using dedicated software (Echopac, GE, Horten, Norway). 
Ejection fraction (EF) was measured by the Simpson biplane method [17]. LV size and mass 
(LVM) were measured [17, 19]; relative wall thickness (RWT) (the sum of posterior and 
septal wall thickness divided by the internal diameter) was calculated as an index of LV 
concentric remodelling [20]. 2D measurements of the basal interventricular septum as well as 
the basal lateral wall were obtained as an additional measure of LV hypertrophy in 
hypertensive heart disease [21].  
 
Doppler outflow analysis 
The baseline CW outflow Doppler traces were analyzed for the purpose of this study, both 
manually and semi-automatically. For the manual analysis, the time from onset of aortic flow 
to peak flow (Tman), as well as the ejection time (ETman) and HR were measured. The ratio 
Tman/ ETman (indicating the position of the peak within the ejection period), as well as the ratio 
ETman/HR (indicating the duration of ejection within the heart cycle), were calculated. The 
manual analysis was blinded to the DSE results as well as to the automatic analysis.  
The automated quantification of the CW outflow Doppler traces was previously described 
[22]. Doppler traces were not calculated, but rather extracted from the ultrasound image. This 
was done using an image segmentation method. In the first step, the image is converted and 
pre-processed to obtain only the forward velocities. On these images, the velocity envelope 
is detected automatically using thresholding. Next, the onset and the end of the aortic flow 
were manually indicated, thus isolating the outflow profile. Since the Doppler trace has to be 
continuous and smooth the constraint was implemented forcing the trace to be piecewise 
polynomial. This was done using two cubic polynomial (i.e functions of the form f(x) = ax3 + 
bx2 + c + d) with demands for the first derivatives to be zero at the beginning and end of the 
signal, as well as in the adjacent points where also the second derivative was forced to be 
equal for both of the adjacent polynomials to satisfy the smoothness criteria  (Figure 1, right). 
From the modelled signals, several parameters describing their shape were extracted. Time 
to peak (Tmod), ejection time (ETmod), rise time (trise) and fall time (tfall) were quantified. Rise 
and fall times were defined from 10% to 90% of the peak (Figure 1, bottom). The ratio 
Tmod/ETmod as well as the ratio ETmod/HR were calculated. Additionally, an asymmetry factor 
(asymm) was calculated as the difference of the area under the curve of left and right half of 
the spectrum normalized by the overall area. A value for asymm lower than 0.25 was 
considered an indicator of an abnormally symmetrical trace.  
Additionally, the development of an intra-ventricular gradient during DSE was defined as a 
late-peaking LV Doppler velocity profile that exceeded the basal maximum velocity by at 
least 1 m/sec [23].  
 
Statistical analysis 
Continuous variables’ data are expressed as mean value ± SD and the unpaired two-tailed 
Student t-test was performed for comparative analysis. Categorical variables are expressed 
as a percentage. For categorical variables, comparisons between groups were made using 
the chi-square test. Results were considered significant at P<0.05. A linear correlation was 
used to test the similarity between the manual and automated analysis. 
 
 
RESULTS 
 
Patient group characteristics and basic echocardiography data  
The basic patient characteristics as well as coronary artery disease severity are provided in 
table 1.  The values of both systolic and diastolic blood pressure (BP) were significantly lower 
in controls while the values of systolic BP exceeded normal values in 66% of patients in 
DSEneg and 71% of patients in DSEpos. The heart rate was significantly higher in DSEpos, 
compared to controls.  
In 15/35 DSEneg patients, a coronary angiogram was performed (which was diagnostically 
inconclusive, or performed due to recurrent chest pain symptoms after previous treatment). 
Five of the DSEneg patients had undergone successful coronary revascularization (one by 
coronary artery bypass grafting - CABG), five had a (remaining) insignificant stenosis. 
Although they had normal rest and stress studies, in six patients, a significant stenosis was 
present at the time of the DSE study (single vessel disease in 1, double in 2, triple in 2 and 
multivessel in 1 patient).  
In DSEpos, significant, non revascularized, coronary artery stenoses were present in 16/44 
patients (6 single vessel disease, 5 double vessel disease, while triple and multivessel 
disease were present in 3 and 2 patients, respectively). Overall, 27/44 patients had previous 
coronary revascularization (14/27 CABG), of these, 9 had a stenosis at time of investigation 
(2 in-stent restenoses and 2 bypass stenoses). 5/44 had an insignificant coronary artery 
stenosis and no angiography data were available for the remaining 5/44 patients.  
The basic echocardiographic measurements are given in table 2. LV mass (ASE formula), 
was significantly higher in DSEpos compared to DSEneg and controls (p=0.01 and p<0.00001, 
respectively) mostly due to larger LV cavity measures. The size of the LV cavity was 
significantly smaller in DSEneg, both in end systole as well as in end diastole. RWT, an 
indicator of concentric hypertrophy, was significantly larger in DSEneg. Patients in DSEneg and 
DSEpos had a notable basal septal thickening/bulge, measuring in average 1.3±0.3 cm, while 
it was significantly smaller in the controls. Furthermore, EF was significantly higher in DSEneg 
compared to the other two groups (p<0.000001 vs. controls and DSEpos). Ejection fraction 
was preserved in all healthy volunteers and patients in DSEneg, while it was reduced in 39% 
of the DSEpos patients. 
Notably, an LV dynamic intracavitary gradient was induced by DSE in 71.4% of DSEneg 
patients and 18.2% of DSEpos. In patients developing an intracavitary gradient, RWT 
(p<0.004 vs. no gradient, p<0.000001 vs. controls) and EF (p<0.0001 vs. controls, 
p<0.00001 vs. no gradient) were significantly larger than in patients who did not develop an 
intracavitary gradient during DSE, or controls.  
 
 
 
Doppler outflow analysis 
Figure 2 shows typical examples (both the raw Doppler trace and the extracted profile) from 
the 3 subgroups. The properties extracted from the aortic flow are shown in table 3.  Figure 3 
shows the correlation between the manual and automated measurements of ejection time 
(ETman versus ETmod; r=0.69) and time to peak velocity (Tman versus Tmod; r=0.56). 
Ejection time corrected by heart rate (ETman or ETmod) was not different among the three 
groups. The absolute time to peak (Tmod) was significantly higher in DSEpos, followed by 
DSEneg and the controls.  
The relative time to peak Tmod/ETmod was the longest in DSEpos; notably, it was found to be 
shorter in DSEneg compared to controls.  
Rise time trise was longest in DSEpos compared to DSEneg (p=0.01) and controls (p=0.02). Fall 
time tfall was shortest in DSEpos, though it was the longest in DSEneg (p<0.005 vs. controls and 
DSEpos). Furthermore, tfall was notably prolonged in the patients who developed an 
intracavitary gradient during DSE (0.17±0.03), compared to the ones without an inducible 
gradient (0.15±0.03, p<0.01) and controls (0.15±0.01, p<0.03).  
Asymm was the lowest in DSEpos, followed by controls and DSEneg (Table 3). An abnormally 
symmetric profile (asymm<0.25) was found in 1/35 (2.9%) of the DSEneg patients and in 
12/44 (27.3%) of the DSEpos patients, while in none of the controls. 
The relations between the EF and asymm, Tmod/ETmod, trise and tfall, as well as LVIDd vs. 
asymm, Tmod/ETmod, trise are shown in figure 4 and figure 5, respectively. No significant 
correlation was found between trise and tfall (r=0.19). Moreover, neither asymm, nor trise or tfall 
seemed to be influenced by systolic blood pressure (r=0.08). 
The difference in values of asymm, Tmod/ETmod, trise and tfall among the three patient groups 
are shown in figure 6.  
In the patients who developed an intracavitary gradient during DSE, tfall was significantly 
prolonged while Tmod/ETmod was significantly shorter compared to the group of patients 
without an inducible intracavitary gradient by DSE (figure 7). 
In the subgroup of patients who underwent coronary angiography, the sensitivity of the DSE 
study in detecting CAD was 76%, while its specificity was 31%. In the same subgroup of 
patients, the sensitivity of the semi-automated method (using the asymmetry factor) was 
35%, while its specificity was 88%. A combined sensitivity of DSE and the semi-automated 
method (using the asymmetry factor) was 58%, while the specificity was 67%. Within the 
DSEpos and DSEneg groups, the sensitivity of the asymmetry factor in detecting the DSE study 
outcome was 27%, while the specificity was 97%.  
 
 
DISCUSSION 
 
In this study, we have observed that the aortic outflow velocity profile is altered in the 
presence of coronary artery disease where in an import portion of patients the flow profile 
becomes much more symmetrical and rounded, whereas it is clearly asymmetrical and 
triangular in normal subjects. On average, in CAD, the rise time prolongs, the time to peak 
velocity is delayed and the fall time shortens. 
Aortic outflow is the result of pressure development and deformation of the LV. Generation of 
pressure within the cavity of the LV is a direct consequence of active force development 
within the myofibres. Once initial force is developed by the contractile elements, the ventricle 
can increase its internal pressure up to the point high enough to open the aortic valve. From 
this moment, the shortening of the contractile elements will decrease the cavity size so that 
its internal blood content is ejected [18, 24]. The velocities with which the blood is ejected 
through the aortic valve depend on the pressure gradient. In the absence of an aortic 
stenosis, this gradient is determined by the developed LV pressure and the pressure in the 
aorta, which depends on the peripheral circulation and the aortic stiffness. In the absence of 
afterload changes, aortic outflow should directly reflect active force development and the 
resulting myocardial deformation. Sabbah et al. have shown that the peak acceleration of 
aortic blood flow assessed non-invasively in patients with a CW Doppler velocity meter is a 
useful indicator of global LV performance, as assessed by EF, while neither peak velocity nor 
the systolic velocity integral related as closely to EF [11]. This was also shown in 
experimental setups [10]. An analysis of aortic wave intensity and aortic velocities during a 
dobutamine infusion showed the increased acceleration of the velocity and a more 
asymmetrical profile with faster deceleration, mainly due to the interaction of the forward and 
backward waves in the aorta [25]. It was also shown that dobutamine provokes an increase 
in aortic acceleration, although the increase was significantly lower in patients with CAD. 
However, no difference in aortic acceleration was found between patients and controls at 
baseline [26]. 
Additionally, in a pig model of myocardial hibernation, Bito and co-authors demonstrated that 
isolated chronically ischaemic myocytes show a reduced and slowed contraction when 
compared to normal myocytes and that they show a significant reduction in active force 
development [16, 27]. Furthermore, several studies on long axis function have demonstrated 
that, in areas affected by CAD, the onset of contraction is delayed, the overall amplitude and 
velocity of contraction may be reduced and its duration prolonged [28, 29, 30].  Hatle and co-
authors showed that the relative timing of the maximal aortic flow occurred later in LV heart 
failure [8]. The same study showed the lowest values of time to peak velocity in patients with 
hyperkinetic heart syndrome or with considerable aortic regurgitation.  
In this study, we hypothesize that the presence of coronary artery disease can result in a 
global decrease in contractility such that the LV is not able to generate the required stroke 
volume anymore when developing (normal) short-lived active contraction force. In order to 
generate enough stroke volume the whole LV will prolong the development of contractile 
force, which, besides a slower increase in the blood velocities through the aortic valve, will 
also result in a longer duration of aortic acceleration and a more symmetrical profile of which 
the bulk of the flow shifts towards the later part of the ejection period. 
This remodelling of the aortic velocity profile can be quantified based on the timing and the 
overall shape of the LV outflow curve. In this study we have analyzed CW Doppler traces in 
patients with and without signs of ischaemic heart disease, as assessed by quantitative DSE. 
We have implemented an automated analysis tool, using modelling of the velocity envelope, 
to measure the time intervals relevant for determining later peaking of the outflow traces in 
CAD.  
Our results show that the shape of the aortic outflow trace may reflect decreased 
contractility: the traces of patients within DSEpos show a tendency towards a more 
symmetrical, later peaking and faster falling curve than in DSEneg patients and normals. 
There was a clearly positive correlation of the relative timing of the peak velocity (Tmod/ETmod) 
with EF and a negative one with LVIDd, as a marker of LV dilatation. Furthermore, we 
observed that an asymm<0.25, indicating a markedly more symmetrical trace, was present in 
only 2.9% patients in DSEneg and 27.3% of patients in DSEpos while it was greater than 0.25 
in all controls. Moreover, asymm proved to be a valid indicator of contractility: it correlated 
well with EF and had a somewhat weaker, negative correlation with LVIDd.   
Although the acceleration of the aortic outflow was previously suggested as a marker of 
contractility [11], the aortic rise time trise showed a weaker correlation both with EF and 
LVIDd, compared to Tmod/ETmod and our measure of curve symmetry (asymm), suggesting 
that not only the initial acceleration, but the whole velocity profile has to be considered to 
describe LV function. 
While we hypothesize that a more symmetrical aortic outflow profile indicates decreased 
global contractility, surprisingly, we found that the patients within the DSEneg group, on 
average, showed a more asymmetrical aortic flow pattern with a shorter Tmod/ETmod and 
prolonged tfall when compared to controls. This group of patients also had a significantly 
higher RWT and EF, as well as higher values of SBP and DBP, compared to the other two 
groups. Additionally, in this DSEneg group, an LV dynamic intracavitary gradient was induced 
by DSE in as much as 71% of the patients while this was observed in only 18% in the DSEpos 
group. This characteristic late and large increase in outflow velocities reflects the dynamic 
nature of an additional pressure gradient developed within the LV when the cavity size 
decreases during ejection [31, 32]. This gradient was previously noted in 21% of patients in a 
series of 57 patients undergoing DSE and was associated with a significantly higher resting 
EF but no evidence of a significant difference in history of hypertension, LV hypertrophy, or 
signs of CAD was present [23]. In another series, the late increase in outflow tract velocities 
was associated with signs of basal septal hypertrophy and smaller LV cavities [33]. In a 
series of 394 patients, 17.5% developed a significant LV outflow gradient, which was 
associated with asymmetrical septal hypertrophy and a lower frequency of wall motion 
abnormalities [34]. Overall, in our group of patients, a significant prolongation of the duration 
of tfall was present in patients who developed an intracavitary gradient compared to the ones 
which had no inducible gradient or controls. This, together with the increased hypertrophy 
and EF, would let us hypothesize that the patients who develop a dynamic gradient during 
the DSE have actually increased contractility at baseline and thus indeed show a more 
asymmetric outflow profile with an earlier peak. The hypertrophy and associated increased 
contractility in these patients might be caused by the transient, exercise induced, increased 
pressure overload due to the development of the gradient. The potential to develop a 
dynamic gradient might be triggered by the localized basal septal hypertrophy, induced by 
the presence of hypertension [21]. 
 
Clinical perspective 
The goal of this study was not to present another non-invasive parameter to be used in 
discrimination CAD patients, but rather to address flow remodelling as a consequence of 
cellular and force remodelling which occurs in ischaemic heart disease. We have shown that 
decreased overall contractility results in a more symmetrical outflow velocity profile. In clinical 
practice, the presence of an abnormally symmetrical profile in an individual patient would 
thus suggest that the global development of contractile force has been remodelled to cope 
with the decreased output resulting from decreased contractility. On the other hand, a very 
asymmetrical and early peaking profile implies increased contractility, which, in the presence 
of (regional) hypertrophy, might induce a dynamic intracavitary gradient. Additionally, these 
patients are prone to Tako-Tsubo cardiomyopathy [35]. 
Incorporating parameters describing the profile of the outflow trace, in the clinical 
echocardiographic measurements  thus provides additional information on myocardial 
function. 
 
LIMITATIONS 
 
Left ventricular outflow velocities represent the pressure gradient between the LV and aorta 
and are thus influenced by either of them. This implies that changes in the peripheral vessel 
tree could influence the flow profile. However, a dynamically increasing resistance in the 
vessel tree, associated with decreased compliance, as expected in CAD, would reduce late 
velocities while the presence of high late velocities should thus be related to prolonged LV 
pressure development. Changes in the isometric contraction duration in itself, would not 
change the measurements since we start quantifying from the opening of the valve. 
However, a lengthening of the isometric contraction time would also be expected with a 
decreased contractility, which would be reflected again in a slower rise time and later 
peaking, as we observe. 
Although contractility was not measured directly, there is a strong body of evidence proving 
that DSE testing, especially including information on changes in local deformation, is 
indicative of increase in contractility. Furthermore, as this was a retrospective study on 
routine clinical data, catheterisation measurements of LV contractility were not available, nor 
was sufficient mitral regurgitation present in most of the patients in order to measure Dp/dt. 
Therefore, we have chosen to subgroup the patients based on the DSE response rather than 
angiographically proven CAD, which then served as an adjunctive marker of LV contractility, 
Moreover, the current study was performed using CW Doppler, which is also influenced by 
velocities in the LV cavity (such as the development of a dynamic gradient). Finally, although 
dobutamine mimics exercise, its effects are quite different in terms of loading as it decreases 
preload and afterload. Therefore, identical effects should not be assumed for exercise 
echocardiography. 
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FIGURE LEGENDS: 
 
Figure 1. Raw aortic outflow continuous wave Doppler trace (top). The piecewise cubic 
model fitted on the original trace and the properties extracted from it (bottom). P - area 
 
Figure 2. Raw continuous wave Doppler trace and extracted profile from the control group 
(left), DSE negative group (middle) and DSE positive group (right). DSE – dobutamine stress 
echocardiography; tr – rise time (dashed line); tf – fall time (dashed line); asymm – 
asymmetry factor. 
 
Figure 3. The correlation between the manual and automated measurements of ejection 
time and time to peak velocity. ETman – ejection time by manual analysis of the Doppler 
signal, ETmod - ejection time by analysis of the modelled signal, Tman - time from onset of 
aortic flow to peak flow by manual analysis of the Doppler signal, Tmod - time from onset of 
aortic flow to peak flow by analysis of the modelled signal. 
 
y = 0.5236x + 0.1466
R2 = 0.4744
0.25
0.3
0.35
0.4
0.45
0.5
0.20 0.25 0.30 0.35 0.40 0.45
ETmod
E
T
m
a
n
y = 0.537x + 0.0266
R2 = 0.3226
0.02
0.04
0.06
0.08
0.10
0.04 0.06 0.08 0.10 0.12 0.14
Tmod
T
m
a
n
 
 
 
 
Figure 4. The correlation between EF and asymm, Tmod/ETmod, trise and tfall. EF – ejection 
fraction, asymm – asymmetry factor, Tmod/ETmod – ratio of time to peak and ejection time flow 
by analysis of the modelled signal, trise – rise time, tfall – fall time, DSEneg – dobutamine stress 
echocardiography negative group, DSEpos - dobutamine stress echocardiography positive 
group. 
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Figure 5. The correlation between LVIDd and asymm, Tmod/ETmod, trise. LVIDd – left 
ventricular internal dimension at end diastole, asymm – asymmetry factor, Tmod/ETmod – ratio 
of time to peak and ejection time flow by analysis of the modelled signal, trise – rise time, tfall – 
fall time, DSEneg – dobutamine stress echocardiography negative group, DSEpos - 
dobutamine stress echocardiography group. 
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Figure 6. The values of asymm, Tmod/ETmod, trise and tfall among the three patient groups. 
asymm – asymmetry factor, Tmod/ETmod – ratio of time to peak and ejection time flow by 
analysis of the modelled signal, trise – rise time, tfall – fall time, DSEneg – dobutamine stress 
echocardiography negative group, DSEpos - dobutamine stress echocardiography positive 
group. 
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Figure 7. The values of EF, RWT, tfall and Tmod/ETmod among the patients grouped in regard 
to inducible intracavity gradient. EF – ejection fraction, RWT – regional wall thickness, tfall – 
fall time, Tmod/ETmod – ratio of time to peak and ejection time flow by analysis of the modelled 
signal, GRADneg – patients without an inducible intracavitary gradient by dobutamine stress 
echocardiography, GRADpos - patients with an inducible intracavitary gradient by dobutamine 
stress echocardiography. 
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Table 1. Basic patient characteristics 
 
  
control group 
(n=31) DSEneg (n=35) DSEpos (n=44) 
Age (years) 59.0±11.5 60.3±8.4  64.7±9.7* 
male/female 15/17 9/26 28/16 
SBP rest (mmHg) 119.7±13.2 154.1±22.3† 146.3±16.7† 
DBP rest (mmHg) 73.3±6.8 82.2±10.9‡ 79.6±11.0§ 
HR rest (/min) 62.9±10.8 67.5±11.2 70.9±10.7§ 
CABG (pts) - 1 14 
PCI (pts) - 4 15 
Insignificant stenosis (pts) - 5 5 
single vessel (pts) - 1 6 
double vessel (pts) - 2 5 
triple vessel (pts) - 2 3 
multi vessel (pts)  1 2 
 
DSE: dobutamine stress echocardiography; DSEneg: patients without resting wall motion 
abnormalities or signs of inducible ischaemia on DSE; DSEpos: patients with resting wall 
motion abnormalities or a positive DSE; SBP: systolic blood pressure; DBP: diastolic blood 
pressure; HR: heart rate; CABG: coronary artery bypass grafting; pts: patients; PCI: 
percutaneous coronary intervention.  
* P<0.05 vs. DSEneg; †P<0.0001 vs. control, ‡ P<0.001 vs. control, § P<0.05 vs. control. 
 
 
 
 
Table 2. Echocardiographic measurements 
 
  
control group 
(n=31) DSEneg (n=35) DSEpos (n=44) 
LVIDd (cm) 4.9±0.5 4.5±0.5* 5.3±0.9†‡ 
LVIDs (cm) 3.0±0.5 2.7±0.6§ 3.5±0.9§‡ 
IVSd (cm) 0.9±0.2 1.1±0.2† 1.1±0.3† 
LVPWd (cm) 0.8±0.2 1.0±0.3† 0.9±0.2† 
IVS bulge (cm) 1.1±0.2 1.3±0.3† 1.2±0.3§ 
lateral wall (cm) 0.9±0.1 1.0±0.2§ 0.9±0.2 
RWT 0.35±0.06 0.47±0.08* 0.38±0.10‡ 
EF (%) 65.4±5.6 75.6±7.9* 57.5±13.9†‡ 
LV mass (g) 167.1±53.3 177.8±58.3 241.8±89.5*║ 
LV mass ASE (g) 145.2±42.7 158.1±46.3 204.4±72,1*║ 
inducible gradient (pts) - 25 8 
 
 DSE: dobutamine stress echocardiography; DSEneg: patients without resting wall motion 
abnormalities or signs of inducible ischaemia on DSE; DSEpos: patients with resting wall 
motion abnormalities or a positive DSE; LVIDd: left ventricular internal diastolic dimension at 
end-diastole; LVIDs: left ventricular internal diastolic dimension at end-systole; IVSd: 
interventricular septum thickness at end-diastole LVPWd: left ventricular posterior wall 
thickness at end-diastole; IVS: interventricular septum; RWT: regional wall thickness; EF: 
ejection fraction; LV: left ventricular; ASE: American Society of Echocardiography; pts: 
patients. 
* P<0.0001 vs. control, † P<0.005 vs. control, ‡P<0.0001 vs. DSEneg, § P<0.05 vs. control, 
║P<0.001 vs. DSEneg 
 
Table 3. Properties extracted from aortic Doppler traces 
 
 
control group 
(n=31) DSEneg (n=35) DSEpos (n=44) 
asymm 0.33±0.06 0.35±0.07 0.30±0.08* 
asymm < 0.25 (%) 0.0 2.9 27.3 
ETmod  293.4±59.3 329.4±33.6† 305.3±37.7* 
ETman 296.0±19.4 324.8±40.5† 304.8±33.5‡ 
ETmod/HR 4.55±1.30 5.12±1.11 4.62±1.22 
ETman/HR 4.59±0.90 5.06±1.27 4.60±1.16 
Tmod 65.66±13.50 65.16±13.81 74.50±18.93 §‡ 
Tman 55.33±10.42 64.49±16.03§ 68.73±15.97║ 
Tmod/ETmod 0.215±0.036 0.199±0.046§ 0.244±0.055§* 
Tman/ETman 0.187±0.036 0.201±0.055 0.228±0.057†‡ 
trise 0.032±0.008 0.032±0.008 0.037±0.010§‡ 
tfall 0.153±0.013 0.168±0.025† 0.146±0.026* 
 
 DSE: dobutamine stress echocardiography; DSEneg: patients without resting wall motion 
abnormalities or signs of inducible ischaemia on DSE; DSEpos: patients with resting wall 
motion abnormalities or a positive DSE; asymm: asymmetry factor; ETmod: ejection time 
derived by mathematical modelling; ETman: ejection time measured manually; HR: heart rate; 
Tmod: time from onset of aortic flow to peak aortic flow derived by mathematical modelling; 
Tman: time from onset of aortic flow to peak aortic flow measured manually; trise: rise time; tfall: 
fall time. 
* P<0.005 vs. DSEneg, † P<0.005 vs. control, ‡ P<0.05 vs. DSEneg, § P<0.05 vs. control, 
║P<0.0001 vs. control. 
